Botanix Pharmaceuticals Ltd

BOT

Company Profile

  • Business description

    Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.

  • Contact

    41 - 47 Colin Street
    Suite 3
    West PerthWA6005
    AUS

    T: +61 865552945

    https://www.botanixpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    1

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,820.306.40-0.07%
CAC 407,828.7873.47-0.93%
DAX 4024,265.12191.69-0.78%
Dow JONES (US)44,416.92233.72-0.52%
FTSE 1008,940.9134.75-0.39%
HKSE24,139.57111.200.46%
NASDAQ20,625.934.74-0.02%
Nikkei 22539,569.6876.68-0.19%
NZX 50 Index12,686.6873.52-0.58%
S&P 5006,262.0518.41-0.29%
S&P/ASX 2008,580.109.10-0.11%
SSE Composite Index3,510.180.500.01%

Market Movers